Talking Biotech: Podcast with Kevin Folta

A science based assessment of new technlogy and the future of food. 100% funded by Kevin Folta.

Archive

Talking Biotech: Florida neurosurgeon Duane Mitchell on how genetic engineering opens doors in cancer fight

| April 9, 2017 |

The newest and most promising therapies for challenging cancers are adopting molecular biology strategies. Brain tumors are especially problematic because their location impedes patient function and presents formidable barriers to surgical treatments. But new molecular approaches show promise.

A series of new techniques from viruses genetically trained to attack the tumor to genetic modifications of immune cells to new types of monoclonal antibodies represent a few of the new tricks researchers are now deploying in the fight against these deadly conditions.

Dr. Duane Mitchell is a Professor at the University of Florida. He is a neurosurgeon that is discovering and refining the leading next-generation therapies. In today’s podcast, he shares his expertise on the new types of technologies and the promise they bring.

Website: Dr. Duane Mitchell and the UF Brain Tumor Immunotherapy Program

Follow Talking Biotech on Twitter @TalkingBiotech

Follow Kevin Folta on Twitter @kevinfolta | Facebook: Facebook.com/kmfolta/ | Lab website: Arabidopsisthaliana.com | All funding: Kevinfolta.com/transparency

Stitcher | iTunes | Player FM | TuneIn

Visit Kevin Folta’s Talking Biotech

For more background on the Genetic Literacy Project, read GLP on Wikipedia